Ask AI about NBpharma
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About NBpharma
Newbridge Pharmaceuticals, a pharmaceutical, biologics, and medical device company, engages in the sale and marketing of healthcare products. It offers oncology and supportive care products, such as CLASTEON, a bisphosphonate, which treats problems associated with bone metastasis; SANCUSO, a granisetron transdermal system for the prevention of chemotherapy induced nausea and vomiting; and GLICONORM, a film-coated divisible tablet for the treatment of non-insulin dependent diabetes mellitus. The company provides therapeutic products for diseases, such as diabetes, obesity, oncology, and cardiovascular diseases, as well as for other metabolic disorders. It serves biotechnology and pharmaceutical companies in the Middle East, Africa, Turkey, and Caspian Regions. Newbridge Pharmaceuticals was founded in 2007 and is based in Dubai, the United Arab Emirates.
- Website
- nbpharma.com
- Phone
- 0114053949
- [email protected]
- Address
- Prince Abdulaziz Ben Mosaed ben Galawy
- Categories
- Pharmaceuticals
